Duration of bronchoprotection of the long-acting muscarinic antagonists tiotropium & glycopyrronium against methacholine-induced bronchoconstriction in mild asthmatics (vol 118, pg 96, 2016)

Blais Christianne M.; Davis Beth E.; Cockcroft Donald W.

首页> 外文期刊>Respiratory medicine >Duration of bronchoprotection of the long-acting muscarinic antagonists tiotropium & glycopyrronium against methacholine-induced bronchoconstriction in mild asthmatics (vol 118, pg 96, 2016)

【24h】

Duration of bronchoprotection of the long-acting muscarinic antagonists tiotropium & glycopyrronium against methacholine-induced bronchoconstriction in mild asthmatics (vol 118, pg 96, 2016)

机译：长效毒蕈碱拮抗剂脱氢吡喃酮和甘油酮对甲素诱导的残留糖尿病（Vol 118，PG 96,2016）的硫化物诱导的支气管中的支气管脱硫和糖酮的持续时间

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Respiratory medicine》 |2017年第2017期|共1页
作者
Blais Christianne M.; Davis Beth E.; Cockcroft Donald W.;
展开▼
作者单位

Univ Saskatchewan Coll Med Dept Physiol 107 Wiggins Rd Saskatoon SK S7N 5E5 Canada;

Univ Saskatchewan Coll Med Dept Physiol 107 Wiggins Rd Saskatoon SK S7N 5E5 Canada;

Univ Saskatchewan Coll Med Dept Physiol 107 Wiggins Rd Saskatoon SK S7N 5E5 Canada;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献

1. Duration of bronchoprotection of the long-acting muscarinic antagonists tiotropium & glycopyrronium against methacholine-induced bronchoconstriction in mild asthmatics (vol 118, pg 96, 2016) [J] . Blais Christianne M., Davis Beth E., Cockcroft Donald W. Respiratory medicine . 2017,第期

机译：长效毒蕈碱拮抗剂脱氢吡喃酮和甘油酮对甲素诱导的残留糖尿病（Vol 118，PG 96,2016）的硫化物诱导的支气管中的支气管脱硫和糖酮的持续时间
2. A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study [J] . Kenneth R Chapman, Kai-Michael Beeh, Jutta Beier, BMC Pulmonary Medicine . 2014,第1期

机译：对COPD患者每日一次长效毒蕈碱拮抗剂格隆溴铵和噻托溴铵的疗效和安全性的盲目评估：GLOW5研究
3. INDACATEROL/GLYCOPYRRONIUM VS SINGLE LONG-ACTING MUSCARINIC ANTAGONIST IN LONG-ACTING BRONCHODILATOR-NAIVE COPD PATIENTS: POOLED ANALYSIS [J] . Kostikas K., Muro S., Yoshisue H., Respirology : . 2019,第S1期

机译：Indacatater r /甘油酮与长效支气管扩张剂-NAIVIVE COPD患者的单长型毒蕈碱拮抗剂：汇总分析
4. A blinded evaluation of the efficacy and safety of glycopyrronium a once-daily long-acting muscarinic antagonist versus tiotropium in patients with COPD: the GLOW5 study [O] . Kenneth R Chapman, Kai-Michael Beeh, Jutta Beier, 2014

机译：对COPD患者每日一次长效毒蕈碱拮抗剂格隆溴铵和噻托溴铵的疗效和安全性的盲目评估：GLOW5研究
5. A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study [O] . Chapman, Kenneth R, Beeh, Kai-Michael, Beier, Jutta, 2015

机译：对COPD患者每日一次长效毒蕈碱拮抗剂格隆溴铵和噻托溴铵的疗效和安全性的盲目评估：GLOW5研究

Duration of bronchoprotection of the long-acting muscarinic antagonists tiotropium & glycopyrronium against methacholine-induced bronchoconstriction in mild asthmatics (vol 118, pg 96, 2016)

著录项

引文网络

相似文献

相关主题

期刊订阅